Home   /   Taxonomy   /   Term

Healthcare

Deals, joint ventures & alliances

Biolidics partners Japan's Sysmex Corp for cancer-related R&D

SINGAPORE (Feb 20): Biolidics Limited has established a strategic partnership with Sysmex Corporation, a Tokyo Stock Exchange-listed supplier of hematology instruments, to collaborate on the development of laboratory assays in the field of circulating tum

Results

Singapore Medical Group reports 17.2% higher 4Q earnings of $2.9 mil on revenue growth

SINGAPORE (Feb 19): Singapore Medical Group (SMG) posted a 17.2% rise in 4Q18 earnings to $2.9 million from $2.5 million a year ago, driven by increased revenue contributions from the health and diagnostic & aesthetic business segments.

Tech

Singapore Medical Group subsidiary launches telehealth platform HiDoc

SINGAPORE (Jan 31): Singapore Medical Group (SMG) subsidiary HiDoc today launched its new telehealth platform, which is meant to provide first-of-its-kind telehealth and video conferencing services while giving accredited specialists access to patient hea

M&A

Best World takes up 12.5% stake in A*STAR biotech start-up for $5.6 mil

SINGAPORE (Jan 14): Best World has agreed to acquire a 15% stake in Celligenics, a biomedical A*STAR spin-off start-up, in two investment phases.  

In print this week

Trouble in paradise for Singapore's policymakers as economic slowdown sets in

SINGAPORE (Jan 11): The headwinds of geopolitical stresses, market turbulence and policy uncertainties in the major global economies are no friend to small, open and trade-­dependent Singapore.

Sector Focus

Global healthcare deals to rise before hitting cyclical trough in 2020: Baker Mckenzie

SINGAPORE (Jan 7): Dealmaking in the global healthcare sector is forecast to rise modestly this year after 2019 “started with a bang” with news of US pharmaceutical giant Bristol-Myers Squibb’s intended acquisition of Celgene for US$74 billion ($100

Update

Raffles Medical announces opening of Chongqing hospital

SINGAPORE (Jan 2): Raffles Medical Group (RMG) says its 700-bed hospital in Chongqing is now open, with a second hospital to open in Shanghai, Pudong Qintan, this year.

Broker's Calls

More challenges loom for First REIT after completion of ownership restructuring: OCBC

SINGAPORE (Dec 13): OCBC Investment Research is maintaining its “hold” call on First REIT with a lower fair value of $1.05 from $1.34 previously, after factoring in various risks pertaining to the REIT’s master leases and portfolio balancing.  

Broker's Calls

Health Management International's outlook still healthy despite 1Q earnings miss, say analysts

SINGAPORE (Nov 19): Phillip Capital and CGS-CIMB Research are maintaining their “buy” and “add” calls on Healthcare Management International (HMI) with the respective target prices of 77 cents and 73 cents.

Results

Clearbridge Health posts smaller 3Q loss of $2.5 mil

SINGAPORE (Nov 12): Clearbridge Health recorded a loss of $2.5 million for the 3Q ended Sept, 21.4% smaller than its net loss of $3.2 million a year ago on higher revenue derived from its newly-commenced businesses.
×